A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS) | Zendy

Nobuko Yamaguchi | Zendy; Sonoko Misawa | Zendy; Yasunori Sato | Zendy; Kengo Nagashima | Zendy; K. Katayama | Zendy; Yukari Sekiguchi | Zendy; Yuta Iwai | Zendy; Hiroshi Amino | Zendy; Tomoki Suichi | Zendy; Takanori Yokota | Zendy; Yoichiro Nishida | Zendy; Nobuo Kohara | Zendy; Koichi Hirata | Zendy; Kazutoshi Nishiyama | Zendy; Ichiro Yabe | Zendy; Kenichi Kaida | Zendy; Norihiro Suzuki | Zendy; Hiroyuki Nodera | Zendy; Shoji Tsuji | Zendy; Haruki Koike | Zendy; Junichi Kira | Zendy; Hideki Hanaoka | Zendy; Susumu Kusunoki | Zendy; Satoshi Kuwabara | Zendy

Open Access

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Author(s) -

Nobuko Yamaguchi,

Sonoko Misawa,

Yasunori Sato,

Kengo Nagashima,

K. Katayama,

Yukari Sekiguchi,

Yuta Iwai,

Hiroshi Amino,

Tomoki Suichi,

Takanori Yokota,

Yoichiro Nishida,

Nobuo Kohara,

Koichi Hirata,

Kazutoshi Nishiyama,

Ichiro Yabe,

Kenichi Kaida,

Norihiro Suzuki,

Hiroyuki Nodera,

Shoji Tsuji,

Haruki Koike,

Junichi Kira,

Hideki Hanaoka,

Susumu Kusunoki,

Satoshi Kuwabara

Publication year - 2016

Publication title -

jmir research protocols

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.378

H-Index - 9

ISSN - 1929-0748

DOI - 10.2196/resprot.6610

Subject(s) - eculizumab , medicine , guillain barre syndrome , complement system , immunology , flaccid paralysis , clinical trial , antibody , paralysis , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research